Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

September 27, 2016 - 4:06 p.m.
Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis CollaborationPrinter Friendly Version 
September 21, 2016 - 5:01 p.m.
Gilead Terminates Phase 2/3 Study of GS-5745 in Patients With Ulcerative ColitisPrinter Friendly Version 

Upcoming Events

There are currently no events scheduled.

Most Viewed Links

Updated 09/23/16
1.SEC Filings
3.Annual Reports
4.Fundamentals - Snapshot
5.Stock Information
* Data collected 09/15/16 - 09/22/16

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Down 1.37 (1.70%)
Data as of 09/27/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Morgan Stanley Global Healthcare Conference

September 12, 2016 9:20 a.m. ET
2016 Wells Fargo Healthcare Conference

September 08, 2016 9:55 a.m. ET